Package 67877-502-30

{"route": ["ORAL"], "spl_id": "32238052-6c4c-4b29-a59e-524c819c69f1", "openfda": {"unii": ["864V2Q084H", "6M97XTV3HD"], "rxcui": ["730861", "730866", "730869", "730872"], "spl_set_id": ["c1204fbe-d086-43cf-bbaa-efec9cd0487c"], "manufacturer_name": ["Ascend Laboratories, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET in 1 BOTTLE (67877-502-30)", "package_ndc": "67877-502-30", "marketing_start_date": "20170814"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (67877-502-90)", "package_ndc": "67877-502-90", "marketing_start_date": "20170814"}], "brand_name": "Amlodipine and olmesartan Medoxomil", "product_id": "67877-502_32238052-6c4c-4b29-a59e-524c819c69f1", "dosage_form": "TABLET", "pharm_class": ["Angiotensin 2 Receptor Antagonists [MoA]", "Angiotensin 2 Receptor Blocker [EPC]", "Calcium Channel Antagonists [MoA]", "Calcium Channel Blocker [EPC]", "Cytochrome P450 3A Inhibitors [MoA]", "Dihydropyridine Calcium Channel Blocker [EPC]", "Dihydropyridines [CS]"], "product_ndc": "67877-502", "generic_name": "Amlodipine and olmesartan Medoxomil", "labeler_name": "Ascend Laboratories, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Amlodipine and olmesartan Medoxomil", "active_ingredients": [{"name": "AMLODIPINE BESYLATE", "strength": "10 mg/1"}, {"name": "OLMESARTAN MEDOXOMIL", "strength": "40 mg/1"}], "application_number": "ANDA209042", "marketing_category": "ANDA", "marketing_start_date": "20170814", "listing_expiration_date": "20261231"}